AKRO - Akero Therapeutics, Inc.
IEX Last Trade
28.2
0.165 0.585%
Share volume: 21,717
Last Updated: Fri 27 Dec 2024 08:30:17 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$28.04
0.17
0.59%
Summary score
21%
Profitability
25%
Dept financing
2%
Liquidity
50%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-34.89%
Return on assets
-18.22%
Return on sales
0%
Return on invested capital
542.87%
Total debt ratio
8.75%
Debt ratio change over timeo
-0.97%
Current Ratio
20.35%
Quick Ratio
0%
Cash Position Ratio
17.4%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-12.16%
Return on assets
-11.7%
Return on sales
0%
Return on invested capital
180.61%
Total debt ratio
6.74%
Debt ratio change over timeo
-0.96%
Current Ratio
15.79%
Quick Ratio
0%
Cash Position Ratio
10.17%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-15.63%
Return on assets
-14.43%
Return on sales
0%
Return on invested capital
170.1%
Total debt ratio
9.11%
Debt ratio change over time
-0.94%
Current Ratio
10.89%
Quick Ratio
0%
Cash Position Ratio
6.09%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-104.96%
Return on assets
-104.77%
Return on sales
0%
Return on invested capital
-20.81%
Total debt ratio
-97.26%
Debt ratio change over time
-0.97%
Current Ratio
6.47%
Quick Ratio
0%
Cash Position Ratio
4.39%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AKRO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -34.89% | -3.05% | 11.55% | 6.27% |
| Return on assets | -18.22% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 542.87% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 36% | 67% | 59% |
| Total debt ratio | 8.75% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.97% | 6.09% | 6.03% | 1.53% |
| Dept financing | 2% | 50% | 43% | 14% |
| Current Ratio | 15.79% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 10.17% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 13% | 30% | 29% |
| Short-term ratios | AKRO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -12.16% | -25.62% | 17.94% | 7.14% |
| Return on assets | -11.7% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 180.61% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 39% | 70% | 60% |
| Total debt ratio | 6.74% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.96% | -23.44% | 9.66% | 0.6% |
| Dept financing | 2% | 25% | 45% | 8% |
| Current Ratio | 15.79% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 10.17% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 24% | 20% | 34% |